NurExone Biologic Inc. (TSXV:NRX)

Canada flag Canada · Delayed Price · Currency is CAD
0.7700
+0.0300 (4.05%)
Aug 13, 2025, 9:30 AM EDT
30.51%
Market Cap 59.21M
Revenue (ttm) n/a
Net Income (ttm) -8.34M
Shares Out 80.01M
EPS (ttm) -0.12
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 8,000
Average Volume 32,393
Open 0.7600
Previous Close 0.7400
Day's Range 0.7600 - 0.7800
52-Week Range 0.5200 - 0.8300
Beta -0.03
RSI 63.26
Earnings Date Aug 26, 2025

About NurExone Biologic

NurExone Biologic Inc., a pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries. It develops and commercializes the ExoTherapy platform for production of exosome-loaded nanodrugs. The company is also developing an off-the-shelf, non-invasive, and novel treatment for the reversal or reduction of paralysis caused by spinal cord injury using membrane-bound extracellular vesicles technology, as well as to treat traumatic brain injuries and other ne... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2020
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol NRX
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.